| 7.12 Data as of May 20 | -0.03 / -0.42%Today’s Change | 6.65 Today|||52-Week Range 10.63 | -6.81% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Durata Therapeutics Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 14.00. The median estimate represents a +110.67% increase from the last price of 7.12.

The current consensus among 4 polled investment analysts is to Buy stock in Durata Therapeutics Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




